| Patients with osteoporosis ( n =1638) | Patients without osteoporosis ( n =6552) | P value | ||
---|---|---|---|---|---|
 | n | % | n | % |  |
Sex | Â | Â | Â | Â | 1 |
 Male | 242 | 14.8 | 968 | 14.8 |  |
 Female | 1396 | 85.2 | 5584 | 85.2 |  |
Age (y) | Â | Â | Â | Â | 1 |
 50–64 | 648 | 39.6 | 2592 | 39.6 |  |
 65–79 | 808 | 49.3 | 3232 | 49.3 |  |
 ≥ 80 | 182 | 11.1 | 728 | 11.1 |  |
Mean ± SD of follow-up (y) |  |  |  |  | < .001 |
 | 4.76 | 0.97 | 4.88 | 0.66 |  |
Urbanization level | Â | Â | Â | Â | 0.037 |
 1 (most urbanized) | 443 | 27.0 | 2010 | 30.7 |  |
 2 | 452 | 27.6 | 1688 | 25.8 |  |
 3 | 229 | 14.0 | 929 | 14.2 |  |
 4 | 264 | 16.1 | 1035 | 15.8 |  |
 5 (least urbanized) | 250 | 15.3 | 890 | 13.6 |  |
Monthly income | Â | Â | Â | Â | 0.006 |
 0 | 567 | 34.6 | 2520 | 38.5 |  |
 NT$ 1–15,840 | 245 | 15.0 | 809 | 12.3 |  |
 NT$ 15,841–25,000 | 695 | 42.4 | 2724 | 41.6 |  |
 NT$ –25,001 | 131 | 8.0 | 499 | 7.6 |  |
Geographic region | Â | Â | Â | Â | < .001 |
 Northern | 687 | 41.9 | 2953 | 45.1 |  |
 Central | 467 | 28.5 | 1630 | 24.9 |  |
 Southern | 355 | 21.7 | 1566 | 23.9 |  |
 Eastern | 129 | 7.9 | 403 | 6.2 |  |
Hypertension | Â | Â | Â | Â | < .001 |
 Yes | 1212 | 74.0 | 4548 | 69.4 |  |
 No | 426 | 26.0 | 2004 | 30.6 |  |
Hyperlipidemia | Â | Â | Â | Â | < .001 |
 Yes | 895 | 54.6 | 2914 | 44.5 |  |
 No | 743 | 45.4 | 3638 | 55.5 |  |
Diabetes | Â | Â | Â | Â | 0.008 |
 Yes | 658 | 40.2 | 2399 | 36.6 |  |
 No | 980 | 59.8 | 4153 | 63.4 |  |
Liver cirrhosis | Â | Â | Â | Â | < .001 |
 Yes | 368 | 22.5 | 900 | 13.7 |  |
 No | 1270 | 77.5 | 5652 | 86.3 |  |
Hemolytic anemia | Â | Â | Â | Â | 0.773 |
 Yes | 2 | 0.1 | 10 | 0.2 |  |
 No | 1636 | 99.9 | 6542 | 99.8 |  |
Spinal cord injury | Â | Â | Â | Â | <.001 |
 Yes | 99 | 6.0 | 17 | 0.3 |  |
 No | 1539 | 94.0 | 6535 | 99.7 |  |
Obesity | Â | Â | Â | Â | 0.826 |
 Yes | 10 | 0.6 | 37 | 0.6 |  |
 No | 1628 | 99.4 | 6515 | 99.4 |  |
Hormone replacement | Â | Â | Â | Â | <.001 |
 Yes | 231 | 14.1 | 298 | 4.5 |  |
 No | 1407 | 85.9 | 6254 | 95.5 |  |
Ceftriaxone | Â | Â | Â | Â | 0.813 |
 Yes | 4 | 0.2 | 14 | 0.2 |  |
 No | 1634 | 99.8 | 6538 | 99.8 |  |
Clofibrate | Â | Â | Â | Â | 0.045 |
 Yes | 1 | 0.1 | Na | Na |  |
 No | 1637 | 99.9 | 6552 | 100.0 |  |
Octreotide | Â | Â | Â | Â | 0.724 |
 Yes | 2 | 0.1 | 6 | 0.1 |  |
 No | 1636 | 99.9 | 6546 | 99.9 |  |
Total parenteral nutrition | Â | Â | Â | Â | 0.070 |
 Yes | 1 | 0.1 | 21 | 0.3 |  |
 No | 1637 | 99.9 | 6531 | 99.7 |  |